Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.71 |
| ▸ | RAB9A | P51151 | 8/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.71 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.71 |
| ▸ | GUSB | P08236 | 1/20 | 0.65 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | PKM | P14618 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30046965 | 1.00 | NPC1 (0.71) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL10041697 | 0.92 | ALDH1A1 (0.65) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL14643717 | 0.90 | NPC1 (0.57) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL12861171 | 0.87 | ALDH1A1 (0.71) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL12861190 | 0.86 | NPC1 (0.74) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL14644293 | 0.86 | NPC1 (0.54) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL7389359 | 0.86 | AMY1A (0.66) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL9888370 | 0.86 | NPC1 (0.69) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL31559156 | 0.86 | AMY1A (0.66) | NPC1RAB9AALDH1A1KDM4EGPR55 | |
| SCHEMBL10041703 | 0.86 | NPC1 (0.56) | NPC1RAB9AALDH1A1KDM4EGPR55 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433929-B | Organic solderability copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-115433929-A | Organic weldable copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-117835585-B | Surface treatment method of circuit board and circuit board manufactured by same | 梅州鼎泰电路板有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117835585-A | Surface treatment method of circuit board and circuit board manufactured by same | 梅州鼎泰电路板有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-115433929-B | Organic solderability copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-115433929-A | Organic weldable copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-109096205-B | Synthesis method of benzimidazole compound | 五邑大学 | 2021-08-10 | — | — | CN | disclosed |
| CN-107312008-B | A kind of catalysis prepares the catalyst and system and method for benzimidazole simultaneously [2,1-b] quinoline -6- ketone derivatives | 马鞍山市泰博化工科技有限公司 | 2019-08-27 | — | — | CN | disclosed |
| CN-107312008-A | A kind of easy catalysis prepares the catalyst and system and method for benzimidazole simultaneously ketone derivatives of [2,1 b] quinoline 6 | 马鞍山市泰博化工科技有限公司 | 2017-11-03 | — | — | CN | disclosed |
| CN-106903455-A | A kind of high temperature resistant organic solderability preservative and apply usage | 长沙理工大学 | 2017-06-30 | — | — | CN | disclosed |
| US-8198307-B2 | Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | TYR, MCHR1, MCHR2 | NPC1 223/4885RAB9A 687/4885ALDH1A1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.